Genflow Biosciences plc
GENF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£1,587 | -£1,629 | -£1,335 | -£988 |
| Dep. & Amort. | £1 | £1 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £72 | £19 |
| Change in WC | £504 | -£28 | -£177 | £172 |
| Other Non-Cash | £0 | £133 | £71 | £50 |
| Operating Cash Flow | -£1,082 | -£1,655 | -£1,369 | -£747 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | -£2 | -£2 | £0 |
| Net Acquisitions | £0 | £0 | £0 | £199 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | £0 | -£2 | -£2 | £199 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £657 | £0 | £3,763 | £784 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £0 | -£263 | £0 |
| Financing Cash Flow | £657 | £0 | £3,500 | £784 |
| Forex Effect | £20 | -£14 | £4 | £0 |
| Net Chg. in Cash | -£405 | -£1,672 | £2,132 | £235 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £684 | £2,356 | £224 | -£11 |
| End Cash | £279 | £684 | £2,356 | £224 |
| Free Cash Flow | -£1,082 | -£1,658 | -£1,371 | -£747 |